Recent research from Northeastern University indicates that pregnancy may significantly alter the way that animals process fear memories. A study published in the journal Hormones and Behavior provides insights into how these neurological changes occur, particularly in the context of postpartum experiences.
The study specifically examined the effects of pregnancy on rats, revealing that both pregnant and postpartum rats displayed a notable reduction in their fear responses compared to a control group of non-pregnant rats. This phenomenon is thought to be influenced by an increase in the steroid allopregnanolone, which is produced in greater quantities during late pregnancy.
Rebecca Shansky, professor and chair of psychology at Northeastern, emphasized the innovative approach of this research, stating, “What’s cutting edge about our study is that it was conducted while the rats were pregnant, and not after the fact.” This approach allowed for a unique examination of the hormonal environment affecting the brain during pregnancy.
The research team, including graduate student Lindsay Vincelette, trained rats to respond to a series of sounds paired with a mild electric shock, creating a Pavlovian conditioning scenario. The results revealed that when exposed to these sounds, both pregnant and postpartum rats were less likely to exhibit the fear responses that had been previously conditioned, while the control group continued to react fearfully.
Analyzing brain activity, the researchers found significant changes in the medial prefrontal cortex, a region associated with executive function. This observation led them to hypothesize that the elevated levels of allopregnanolone during late pregnancy may contribute to these altered fear responses. “Allopregnanolone’s function during pregnancy has yet to be fully explored,” Shansky noted, highlighting its potential role in mood regulation.
To further investigate this relationship, the researchers administered the drug finasteride to a separate group of pregnant rats during the final six days of pregnancy. Finasteride inhibits the metabolization of progesterone into allopregnanolone. The hypothesis was that a reduction in allopregnanolone levels would lead to an increased retention of fear memories.
The results supported this hypothesis, revealing that the rats with decreased allopregnanolone levels exhibited a return of their fear responses, but intriguingly, only among the “non-darters,” who typically freeze in the face of fear. This distinction suggests that the underlying mechanisms influencing these behaviors may vary between different types of rats, indicating deeper biological differences.
Despite these findings, Shansky and Vincelette acknowledged the need for further research to clarify open questions regarding their methodology. One crucial consideration is whether the altered fear responses in non-darting rats could be attributed to increased progesterone levels rather than the absence of allopregnanolone. Future experiments will employ a custom-designed virus to block the receptors that allopregnanolone typically binds to, allowing researchers to measure the effects of progesterone more accurately.
While the long-term implications of these changes in fear memory remain to be fully understood, Shansky suggested that the effects observed are likely more enduring than what would result from temporary exhaustion due to the demands of motherhood. “That’s why we think that, at the very least, the experience of pregnancy is something that has long-lasting neurological effects,” she stated.
Ultimately, the research aims to address a fundamental question: “How does being pregnant change your brain in a really long-term, stable way?” The findings from this study may not only deepen the understanding of pregnancy’s impact on brain function but could also have broader implications for understanding maternal mental health.
For further details, refer to the original study by Lindsay K. Vincelette et al., titled “Pregnancy’s lasting imprint: Late pregnancy allopregnanolone alters rat fear recall and medial prefrontal cortex activity,” set to be published in 2026.
